Modulators Of Dnm2 Expression Freier; Susan M. ; et al. [Ionis Pharmaceuticals, Inc.]

$ 34.00

4.7 (385) In stock

U.S. Patent Application 20190241896 for Modulators Of Dnm2 Expression

EP0517796B1 - Oligonucleotide analogs - Google Patents

A DNM2 Centronuclear Myopathy Mutation Reveals a Link between Recycling Endosome Scission and Autophagy - ScienceDirect

PDF) Likelihood of Nonspecific Activity of Gapmer Antisense Oligonucleotides Is Associated with Relative Hybridization Free Energy

PDF) Likelihood of Nonspecific Activity of Gapmer Antisense Oligonucleotides Is Associated with Relative Hybridization Free Energy

WO1992005186A1 - Modified internucleoside linkages - Google Patents

Brett P. Monia's research works Ionis Pharmaceuticals, Carlsbad and other places

SEC Filing Sarepta Therapeutics, Inc.

A DNM2 Centronuclear Myopathy Mutation Reveals a Link between Recycling Endosome Scission and Autophagy - ScienceDirect

Shuling GUO, Director, Doctor of Philosophy, Ionis Pharmaceuticals, Carlsbad, Antisense Drug Discovery

A DNM2 Centronuclear Myopathy Mutation Reveals a Link between Recycling Endosome Scission and Autophagy - ScienceDirect

Assembly and disassembly dynamics of nonmuscle myosin II control endosomal fission - ScienceDirect

Surface-induced dissociation of protein complexes on a cyclic ion mobility spectrometer - Analyst (RSC Publishing) DOI:10.1039/D1AN01407B

US20050245475A1 - Functional and hyperfunctional siRNA directed against Bcl-2 - Google Patents

Frontiers Integrating the potential of ion mobility spectrometry-mass spectrometry in the separation and structural characterisation of lipid isomers